Roche CEO declines to stamp out Alexion deal rumors
July 25, 2013 at 01:20 AM EDT
Roche CEO Daniel O'Day declined to comment on market rumors that the Swiss pharmaceutical giant is about to bid for Alexion, but told CNBC that one of the key strategies for the company is to look for new drugs that could be incorporated into its portfolio.
